Chartwell Partners, a national leader in executive search services, announced today that Sara Hagar has joined the firm as a Partner, leading the Biopharmaceuticals and Life Sciences Practice. Sara’s appointment builds upon Chartwell’s established reputation as a premier provider of recruitment advisory services for healthcare, consumer, industrial and financial services clients ranging from Fortune 1000 companies to early stage enterprises, as well as private equity firms and their portfolio investments.
Chartwell’s Healthcare Sector is privileged to serve a client base that spans the complete continuum of the market from the discovery, development, commercialization and manufacturing of innovative therapeutics and medical technologies, to physician management, HCIT, insurance, healthcare delivery and patient care.
Sara began her recruiting career in 1990, focusing exclusively in the biopharmaceuticals and life sciences sector since 1991. Her search work includes Board, CEO and other C-level positions across all functional disciplines with an emphasis on highly innovative, emerging therapeutics companies approaching their key inflection points.
Prior to Chartwell Partners, Sara was a Partner with Catalyst Advisors LP, a firm she joined at its inception in 2008. Earlier in her career, she was a member of the Healthcare Sector at Russell Reynolds Associates in the San Francisco, Menlo Park and Washington, D.C. offices.
Sara is based in Philadelphia where she joins Partner, Mike DeSantis, whose practice focuses on serving clients in health insurance, healthcare technology and technology enabled service providers.
Chartwell Partners is uniquely positioned to identify and attract leaders across the ever-expanding healthcare landscape and take advantage of the convergence of industries and acumen needed to accelerate true healthcare related advancements and ROI.